Topiramate reduces heavy drinking among patients seeking to cut down on alcohol consumption
Heavy alcohol consumption is common in the United States and takes a personal and societal toll, with an annual estimated cost of 3.5 billion. Researchers have shown that the anticonvulsant medication, topiramate, previously shown to reduce drinking in patients committed to abstinence from alcohol, can also be helpful in treating problem drinkers whose aim is to curb their alcohol consumption ? particularly among a specific group of patients whose genetic makeup appears to be linked to the efficacy of the therapy.
View full story